Recap: Viking Therapeutics Q3 Earnings

Viking Therapeutics VKTX reported its Q3 earnings results on Wednesday, October 26, 2022 at 04:05 PM.

Here's what investors need to know about the announcement.

Earnings

Viking Therapeutics beat estimated earnings by 8.7%, reporting an EPS of $-0.21 versus an estimate of $-0.23.

Revenue was down $0 from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.02 which was followed by a 0.31% increase in the share price the next day.

To track all earnings releases for Viking Therapeutics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.